Potter, Andrew

United States Food and Drug Administration

1 paper on CoChatORCID 0000-0002-0823-8035

Most cited papers

Verified
Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class
Kim, J., Farchione, T., Potter, A., Chen, Q., & Temple, R. (2019) · New England Journal of Medicine
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 333

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free